Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000680957 | SCV000808406 | likely benign | not provided | 2021-09-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000680957 | SCV001017800 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193628 | SCV001362582 | benign | not specified | 2019-12-23 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV000680957 | SCV002009534 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813543 | SCV002060537 | benign | Noonan syndrome and Noonan-related syndrome | 2021-03-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424577 | SCV002728550 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-01-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000680957 | SCV004033928 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | LZTR1: BP7, BS2 |